318 related articles for article (PubMed ID: 18757109)
1. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
[TBL] [Abstract][Full Text] [Related]
2. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
3. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.
Katzmarzyk PT; Church TS; Blair SN
Arch Intern Med; 2004 May; 164(10):1092-7. PubMed ID: 15159266
[TBL] [Abstract][Full Text] [Related]
4. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
5. A single risk factor measurement predicts 35-year mortality from cardiovascular disease.
Menotti A; Giampaoli S
G Ital Cardiol; 1998 Dec; 28(12):1354-62. PubMed ID: 9887388
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.
Hu G; Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Pyorala K;
Arch Intern Med; 2004 May; 164(10):1066-76. PubMed ID: 15159263
[TBL] [Abstract][Full Text] [Related]
7. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Heng D; Ma S; Chew SK; Hughes K; Tai ES
Clin Endocrinol (Oxf); 2008 Aug; 69(2):225-30. PubMed ID: 18208579
[TBL] [Abstract][Full Text] [Related]
9. Revised Adult Treatment Panel III guidelines and cardiovascular disease mortality in men attending a preventive medical clinic.
Ardern CI; Katzmarzyk PT; Janssen I; Church TS; Blair SN
Circulation; 2005 Sep; 112(10):1478-85. PubMed ID: 16129792
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women.
Jarvis CM; Hayman LL; Braun LT; Schwertz DW; Ferrans CE; Piano MR
J Cardiovasc Nurs; 2007; 22(6):429-35. PubMed ID: 18090180
[TBL] [Abstract][Full Text] [Related]
11. The association between ankle-brachial index and cardiovascular or all-cause mortality in metabolic syndrome of elderly Chinese.
Xu Y; Li J; Luo Y; Wu Y; Zheng L; Yu J; Ma J; Gu J; Hu D
Hypertens Res; 2007 Jul; 30(7):613-9. PubMed ID: 17785929
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study.
Thomas GN; Schooling CM; McGhee SM; Ho SY; Cheung BM; Wat NM; Janus ED; Lam KS; Lam TH;
Clin Endocrinol (Oxf); 2007 May; 66(5):666-71. PubMed ID: 17381490
[TBL] [Abstract][Full Text] [Related]
13. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
[TBL] [Abstract][Full Text] [Related]
14. Influence of pre-hypertension on all-cause and cardiovascular mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Heng D; Ma S; Chew SK; Hughes K; Tai ES
Int J Cardiol; 2009 Jul; 135(3):331-7. PubMed ID: 18582967
[TBL] [Abstract][Full Text] [Related]
15. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
DECODE Study Group
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
[TBL] [Abstract][Full Text] [Related]
16. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up.
Hozawa A; Okamura T; Murakami Y; Kadowaki T; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Abbott RD; Okayama A; Ueshima H;
Hypertens Res; 2007 Dec; 30(12):1169-75. PubMed ID: 18344621
[TBL] [Abstract][Full Text] [Related]
17. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality.
Ho JS; Cannaday JJ; Barlow CE; Mitchell TL; Cooper KH; FitzGerald SJ
Am J Cardiol; 2008 Sep; 102(6):689-92. PubMed ID: 18773989
[TBL] [Abstract][Full Text] [Related]
18. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Ma S; Heng D; Chew S; Hughes K; Tai E
J Hum Hypertens; 2008 Jul; 22(7):468-74. PubMed ID: 18337755
[TBL] [Abstract][Full Text] [Related]
19. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk?
Gao W;
Int J Obes (Lond); 2008 May; 32(5):757-62. PubMed ID: 18209738
[TBL] [Abstract][Full Text] [Related]
20. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000.
Kadota A; Hozawa A; Okamura T; Kadowak T; Nakmaura K; Murakami Y; Hayakawa T; Kita Y; Okayama A; Nakamura Y; Kashiwagi A; Ueshima H;
Diabetes Care; 2007 Jun; 30(6):1533-8. PubMed ID: 17363755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]